Funding Agency:
BHR Pharma, LLC
Total Project Period:
04/21/10 - 04/20/12
Total Project Award:
$115,000
Principal Investigator:
David O. Okonkwo, MD, PhD
Co-Investigators:
Richard M. Spiro, MD; Richard Spiro, MD; Samuel Tisherman, MD, Ava Puccio, PhD
Project Summary:
The primary objective of this clinical outcomes study is to investigate the efficacy and safety of progesterone in patients with severe traumatic brain injury. |